Notes
Patient demographics were obtained via a personal communication with the corresponding author.
Reference
Cencini E, et al. Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma. Leukemia and Lymphoma 60: 833-835, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1080/10428194.2018.1504938 -Italy
Rights and permissions
About this article
Cite this article
Bendamustine/rituximab. Reactions Weekly 1753, 72 (2019). https://doi.org/10.1007/s40278-019-61964-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-61964-2